Johnson Controls Files US. Patent Application And receives US Patent Approval For OpenBlue Energy Optimization Innovations

Johnson Controls (NYSE:JCI), the global leader for smart, healthy and sustainable buildings, today announced it has surpassed a milestone by filing 200 U.S. utility patent applications for innovations

Johnson Controls (NYSE:JCI), the global leader for smart, healthy and sustainable buildings, today announced it has surpassed a milestone by filing 200 U.S. utility patent applications for innovations surrounding its OpenBlue Central Utility Plant offering and related energy optimizing product offerings. Additionally, it received its 90th U.S. patent grant for innovations related to OpenBlue Central Utility Plant product and energy optimization innovations. Central Utility Plant is a key component of the newly announced OpenBlue NetZero Buildings as a Service offering. 

The most recent grants, U.S. Pat. No. 11,061,424, awarded July 13th, 2021, and U.S. Pat. No. 11,036,249, awarded June 15, 2021, include innovations which allow for a building energy optimizer to predict regional peak demand time periods. Peak regional demand (associated with both high cost and high emissions) predicted by the Johnson Controls system can be used to optimize energy performance based on the probability that any given period of time will be a peak contribution period. 

Total
0
Shares
Related Posts
Read More

Homology Medicines Announces Presentations On HMI-203 Investigation Gene Therapy For Hunter Syndrome And Broad Applicability Of AAVHSC Platform For Lysosomal Storage Disorders At The 18th Annual WORLDSymposium Meeting

 Homology Medicines, Inc. (NASDAQ:FIXX), a genetic medicines company, announced today multiple presentations on HMI-203 gene therapy candidate for the treatment of Hunter syndrome (MPS II), which is being evaluated

FIXX